Search results for "3H"

showing 10 items of 259 documents

CCDC 1839832: Experimental Crystal Structure Determination

2018

Related Article: Gustavo Portalone, Kari Rissanen|2018|Cryst.Growth Des.|18|5904|doi:10.1021/acs.cgd.8b00662

Space GroupCrystallographybis(5-iodopyrimidine-24(1H3H)-dione) pyrimidine-246-triamine dihydrateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1553257: Experimental Crystal Structure Determination

2017

Related Article: Matteo Savastano, Paloma Arranz-Mascaros, ́Carla Bazzicalupi, Maria Paz Clares, Maria Luz Godino-Salido, Lluis Guijarro, Maria Dolores Gutierrez-Valero, ́Antonio Bianchi, Enrique García-España, Rafael Lopez-Garzon|2017|ACS Omega|2|3868|doi:10.1021/acsomega.7b00736

Space GroupCrystallographycatena-[(mu-6-amino-3-methyl-5-nitroso-2-({2-[36915-tetraazabicyclo[9.3.1]pentadeca-1(15)1113-trien-6-yl]ethyl}amino)pyrimidin-4(3H)-one)-copper(ii) diperchlorate]Crystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 2132446: Experimental Crystal Structure Determination

2022

Related Article: Cristina Negro, Paula Escamilla, Rosaria Bruno, Jesus Ferrando-Soria, Donatella Armentano, Emilio Pardo|2022|Chem.-Eur.J.|28||doi:10.1002/chem.202200034

Space GroupCrystallographycatena-[6-(dimethylamino)-NN-dimethyl-3H-xanthen-3-iminium chloride tris(mu-[1-carboxylato-3-(methylsulfanyl)propyl]({[1-carboxylato-3-(methylsulfanyl)propyl]carboximidato}carbonyl)amido)-bis(mu-hydroxo)-(mu-aqua)-hexa-copper(ii)-strontium(ii) hexahydrate]Crystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Mycoplasma fermentans-derived lipid inhibits class II major histocompatibility complex expression without mediation by interleukin-6, interleukin-10,…

1996

Mycoplasma cause several diseases in man and animals. Some strains can chronically infect humans, leading to fever or inflammatory syndromes such as arthritis, particularly in immunosuppressed patients. A set of pathogenicity factors shared by many mollicutes may be membrane components that activate macrophages to secrete cytokines and other inflammatory mediators. Mycoplasma-derived high molecular weight material (MDHM) is a macrophage-activating amphiphilic lipid which was purified from Mycoplasma fermentans. We studied the influence of MDHM on the expression of major histocompatibility complex (MHC) class II molecules by mouse resident peritoneal macrophages with an ELISA. Highly purifie…

T cellImmunologyAntigen presentationBiologyNitric OxideMajor histocompatibility complexMicrobiologyMiceAntigenTransforming Growth Factor betaInterferonMHC class ImedicineAnimalsImmunology and AllergyMycoplasma fermentansCells CulturedMycoplasma fermentansMice Inbred C3HInterleukin-6Tumor Necrosis Factor-alphaHistocompatibility Antigens Class IIInterleukinbiology.organism_classificationLipidsInterleukin-10Molecular WeightKineticsmedicine.anatomical_structureInterferon Type IImmunologyProstaglandinsbiology.proteinCytokinesFemaleImmunosuppressive Agentsmedicine.drugEuropean Journal of Immunology
researchProduct

Synthesis and antiproliferative activities of two new analogs of tetrazepinones

Based on the encouraging results, we report the multistep synthesis and the biologicalo results of two new analogs of tetrazepinones: the 3,5-dimethyl-6-phenyl-8-(trifluoromethyl-5,6-dihydropyrazo1o[3-4-f]1,2,35)tetrazepin-4(3H)-one and the 3-(2-chloroethyl)-5-methyl-6-phenyl-8-(trifluoromethyl-5,6-dihydropyrazo1o[3-4-f]1,2,35)tetrazepin-4(3H)-one. Both compounds showed a pro-apoptotic activity against HL60 and K562 resistant cell lines. Flow cytometry studies carried out 0n K562 cells allowed to establish that the methyl derivative induces G0-G1, phase arrest followed by apoptosis, whereas the chloroethyl derivative is a not phase-specific agent.

Telozolomide 35-dimethyl-6-phenyl-8-(trifluoromethyl-56-dihydropyrazo1o[3-4-f]1235)tetrazepin-4(3H)-one 3-(2-chloroethyl)-5-methyl-6-phenyl-8-(trifluoromethyl-56-dihydropyrazo1o[3-4-f]1235)tetrazepin-4(3H)-one pro-apoptotic activity G0-G1 phase arrestSettore BIO/10 - BiochimicaSettore CHIM/08 - Chimica Farmaceutica
researchProduct

The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitro.

1999

Interleukin-6 (IL-6) triggers pivotal pathways in vivo. The designer protein hyper-IL-6 (H-IL-6) fuses the soluble IL-6 receptor (sIL-6R) through an intermediate linker with IL-6. The intracellular pathways that are triggered by H-IL-6 are not defined yet. Therefore, we studied the molecular mechanisms leading to H-IL-6-dependent gene activation. H-IL-6 stimulates haptoglobin mRNA expression in HepG2 cells, which is transcriptionally mediated as assessed by run-off experiments. The increase in haptoglobin gene transcription correlates with higher nuclear translocation of tyrosine-phosphorylated STAT3 and its DNA binding. As H-IL-6 stimulates STAT3-dependent gene transcription, we compared t…

Therapeutic gene modulationSTAT3 Transcription FactorTranscriptional ActivationTranscription GeneticRecombinant Fusion ProteinsResponse elementE-boxBiologyTransfectionBiochemistryCell LineMiceSp3 transcription factorAntigens CDCytokine Receptor gp130E2F1AnimalsHumansRNA MessengerPhosphorylationMolecular BiologyCell NucleusATF3Sp1 transcription factorMice Inbred C3HMembrane GlycoproteinsHaptoglobinsInterleukin-6Liver receptor homolog-1Biological TransportCell BiologyDNAReceptors InterleukinMolecular biologyReceptors Interleukin-6DNA-Binding ProteinsGene Expression RegulationTrans-ActivatorsTyrosineThe Journal of biological chemistry
researchProduct

Dendritic cell aggresome-like-induced structure formation and delayed antigen presentation coincide in influenza virus-infected dendritic cells.

2005

Abstract Influenza virus infection induces maturation of murine dendritic cells (DCs), which is most important for the initiation of an immune response. However, in contrast to EL-4 and MC57 cells, DCs present viral CTL epitopes with a delay of up to 10 h. This delay in Ag presentation coincides with the up-regulation of MHC class I molecules as well as costimulatory molecules on the cell surface and the accumulation of newly synthesized ubiquitinated proteins in large cytosolic structures, called DC aggresome-like-induced structures (DALIS). These structures were observed previously after LPS-induced maturation of DCs, and it was speculated that they play a role in the regulation of MHC cl…

Time FactorsImmunologyAntigen presentationCellAntigen-Presenting CellsEpitopes T-Lymphocytechemical and pharmacologic phenomenaBone Marrow CellsVirusCell LineMiceImmune systemCell Line TumorMHC class ImedicineImmunology and AllergyAnimalsHumansReceptors ImmunologicCells CulturedAntigen PresentationMice Inbred C3HbiologyUbiquitinViral Core ProteinsRNA-Binding ProteinsCell DifferentiationDendritic cellDendritic CellsNucleocapsid ProteinsVirologyToll-Like Receptor 2Cell biologyNucleoproteinMice Inbred C57BLToll-Like Receptor 4Aggresomemedicine.anatomical_structureNucleoproteinsInfluenza A virusbiology.proteinCytoplasmic StructuresT-Lymphocytes CytotoxicJournal of immunology (Baltimore, Md. : 1950)
researchProduct

Interleukin-4 induces secretion of CSF for granulocytes and CSF for macrophages by peripheral blood monocytes.

1989

Abstract T cells are known to interact cooperatively with monocytes to produce Colony-Stimulating Factors (CSF), although T cell-mediated signals leading to CSF secretion by monocytes are not completely understood. We have made use of Northern blot hybridization and specific bioassays to study the effects of the T cell product interleukin-4 (IL-4) on monocyte CSF expression. The results suggest a previously unrecognized role of IL-4 as a CSF inducer since exposure of monocytes to IL-4 resulted in accumulation of transcripts for granulocyte-CSF (G-CSF) and macrophage-CSF (M-CSF). Consequently, IL-4-activated monocytes released factors in their culture supernatants biologically and antigenica…

Transcription GeneticT cellImmunologyBiologyBiochemistryMonocytesColony-Forming Units AssayMiceColony-Stimulating FactorsGranulocyte Colony-Stimulating FactormedicineBioassayAnimalsHumansInducerSecretionNorthern blotInterleukin 4Mice Inbred C3HMonocyteInterleukinsMacrophage Colony-Stimulating FactorMacrophagesCell BiologyHematologyMolecular biologyPeripheral bloodRecombinant Proteinsmedicine.anatomical_structureImmunologyInterleukin-4GranulocytesBlood
researchProduct

Benzo[b]oksepīn-2(3H)-ona arilatvasinājumu sintēze

2018

Benzo[b]oksepīn-2(3H)-ona arilatvasinājumu sintēze. Pudnika L., zinātniskais vadītājs Dr. chem., vadošā pētniece Grandāne A., Dr. chem., asoc. prof. Prikšāne A. Bakalaura darbs, 43 lappuses, 22 attēli, 8 tabulas, 35 literatūras avoti. Latviešu valodā. Darbā tika sintezēti benzo[b]oksepīn-2(3H)-ona arilatvasinājumi. Sintezēto benzo[b]oksepīn-2(3H)-ona atvasinājumu struktūra tika pierādīta ar KMR spektroskopiju. Literatūras apskatā apkopota informācija par benzo[b]oksepīn-2(3H)-ona atvasinājumu sintēzes metodēm.

WITTIG REAKCIJABENZO[b]OKSEPĪN-2(3H)-ONSSUZUKI REAKCIJAĶīmijaSTILLE REAKCIJA
researchProduct

CCDC 1839829: Experimental Crystal Structure Determination

2018

Related Article: Gustavo Portalone, Kari Rissanen|2018|Cryst.Growth Des.|18|5904|doi:10.1021/acs.cgd.8b00662

bis(5-bromo-1-methylpyrimidine-24(1H3H)-dione) 135-triazine-246-triamineSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct